Hologic (HOLX) Competitors $63.86 +0.60 (+0.95%) Closing price 04:00 PM EasternExtended Trading$62.95 -0.91 (-1.42%) As of 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. DXCM, HQY, HSIC, MASI, MMSI, ALC, AMN, AVNS, PEN, and ZBHShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Masimo (MASI), Merit Medical Systems (MMSI), Alcon (ALC), AMN Healthcare Services (AMN), Avanos Medical (AVNS), Penumbra (PEN), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector. Hologic vs. Its Competitors DexCom HealthEquity Henry Schein Masimo Merit Medical Systems Alcon AMN Healthcare Services Avanos Medical Penumbra Zimmer Biomet Hologic (NASDAQ:HOLX) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability. Does the media refer more to HOLX or DXCM? In the previous week, Hologic had 3 more articles in the media than DexCom. MarketBeat recorded 22 mentions for Hologic and 19 mentions for DexCom. DexCom's average media sentiment score of 1.44 beat Hologic's score of 1.09 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 13 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 15 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer HOLX or DXCM? Hologic presently has a consensus price target of $77.33, indicating a potential upside of 21.10%. DexCom has a consensus price target of $99.60, indicating a potential upside of 18.39%. Given Hologic's higher probable upside, analysts clearly believe Hologic is more favorable than DexCom.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.47DexCom 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 2.91 Which has more volatility and risk, HOLX or DXCM? Hologic has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Do insiders & institutionals hold more shares of HOLX or DXCM? 94.7% of Hologic shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 1.9% of Hologic shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is HOLX or DXCM more profitable? Hologic has a net margin of 13.83% compared to DexCom's net margin of 12.90%. DexCom's return on equity of 30.05% beat Hologic's return on equity.Company Net Margins Return on Equity Return on Assets Hologic13.83% 19.71% 10.87% DexCom 12.90%30.05%10.00% Which has stronger valuation & earnings, HOLX or DXCM? Hologic has higher earnings, but lower revenue than DexCom. Hologic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B3.53$789.50M$2.3726.95DexCom$4.03B8.18$576.20M$1.3462.78 SummaryDexCom beats Hologic on 10 of the 17 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.10B$6.58B$5.52B$9.32BDividend YieldN/A1.30%4.25%4.05%P/E Ratio26.9525.4928.1519.68Price / Sales3.5367.67438.33100.29Price / Cash11.5020.0535.5357.53Price / Book2.894.668.235.67Net Income$789.50M$174.76M$3.23B$257.51M7 Day Performance-3.02%-1.13%-0.01%0.52%1 Month Performance-2.03%1.21%5.61%8.84%1 Year Performance-18.61%2.34%26.52%14.18% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.6326 of 5 stars$63.86+0.9%$77.33+21.1%-18.2%$14.10B$4.03B26.957,063Positive NewsAnalyst ForecastDXCMDexCom4.7821 of 5 stars$82.94+0.0%$98.50+18.8%-25.0%$32.52B$4.03B61.9010,300Positive NewsAnalyst ForecastHQYHealthEquity3.0088 of 5 stars$101.83-0.3%$118.09+16.0%+24.8%$8.81B$1.20B74.333,120Positive NewsHSICHenry Schein4.2683 of 5 stars$73.45-1.6%$79.30+8.0%+7.3%$8.94B$12.67B22.9525,000Trending NewsAnalyst DowngradeAnalyst RevisionMASIMasimo4.1945 of 5 stars$162.45-3.1%$191.60+17.9%+47.0%$8.81B$2.09B-17.725,600Analyst ForecastMMSIMerit Medical Systems4.6258 of 5 stars$91.12-2.6%$109.11+19.7%+9.3%$5.39B$1.36B44.677,400Positive NewsAnalyst ForecastALCAlcon2.6134 of 5 stars$86.81-1.1%$106.13+22.2%-4.4%$42.82B$9.91B38.5825,599Analyst ForecastHigh Trading VolumeAMNAMN Healthcare Services4.2438 of 5 stars$21.23-3.1%$32.08+51.1%-61.5%$812.68M$2.98B-4.902,968AVNSAvanos Medical2.8694 of 5 stars$11.87-3.9%N/A-44.8%$548.87M$687.80M-1.422,227News CoveragePENPenumbra4.7411 of 5 stars$248.05-1.2%$302.40+21.9%+23.4%$9.61B$1.19B234.014,500ZBHZimmer Biomet4.9499 of 5 stars$92.58-1.2%$111.33+20.3%-11.8%$18.32B$7.68B20.4817,000News CoverageAnalyst Upgrade Related Companies and Tools Related Companies DexCom Alternatives HealthEquity Alternatives Henry Schein Alternatives Masimo Alternatives Merit Medical Systems Alternatives Alcon Alternatives AMN Healthcare Services Alternatives Avanos Medical Alternatives Penumbra Alternatives Zimmer Biomet Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOLX Stock Alerts